NCT06564155View on ClinicalTrials.gov

Inturlekin L33 in Ankylosing Spondylities Patients and Its Relation to Subclinical Atherosclerosis

Not yet recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Ankylosing Spondylitis
Interventions
DEVICE

carotid duplex

measure Carotid intima media thickness

All Listed Sponsors
lead

Assiut University

OTHER

NCT06564155 - Inturlekin L33 in Ankylosing Spondylities Patients and Its Relation to Subclinical Atherosclerosis | Biotech Hunter | Biotech Hunter